Monday, September 30, 2019

NIDCR Science News - September 2019

How does a mouse's tooth grow?

Having trouble viewing this email? View it as a Web page.

national institute of dental and craniofacial research

A monthly update of NIDCR-supported science advances, as reported by grantee institutions and NIH. 


   

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Dental and Craniofacial Research · 9000 Rockville Pike · Bethesda, MD 20892 GovDelivery logo

NIH Forms New Collaborative Influenza Vaccine Research Network

The Collaborative Influenza Vaccine Innovation Centers (CIVICs) will work together in a coordinated, multidisciplinary effort.
NIAID Logo

Monday, September 30, 2019

NIH Forms New Collaborative Influenza Vaccine Research Network

Swine flu

As part of its ongoing commitment to developing better influenza vaccines, NIAID is establishing a network of research institutes known as the Collaborative Influenza Vaccine Innovation Centers (CIVICs) that will work together to coordinate their research on improving influenza vaccines. Each component of the network will have a role to play in designing, manufacturing and testing potential new influenza vaccines, as well as analyzing experimental results.

Read More


This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107 GovDelivery logo

NIH forms new collaborative influenza vaccine research network

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).

 

09/30/2019 02:00 PM EDT

The CIVICs program is a new network of research centers that will work together to develop more durable, broadly protective and longer-lasting influenza vaccines.

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institutes of Health (NIH) · 9000 Rockville Pike · Bethesda MD 20892 · 301-496-4000 / TTY 301-402-9612 GovDelivery logo

NIH announces winners of nationwide essay contest for high schoolers about mental health

 

NIMH News Header

Having trouble viewing this email? View it as a Web page.

The National Institutes of Health is pleased to congratulate the winners of the Speaking Up About Mental Health national essay challenge, which was designed to spur conversations about mental health and encourage youth to seek help for mental health issues.

Ten winners and two honorable mentions were selected from among more than 160 teens from across the U.S. and Puerto Rico who opened up the conversation about the impact of mental illness among teens, barriers faced when seeking treatment, and innovative approaches to overcoming those barriers. 

Essay contest winners
Read the winning essays

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Mental Health · 6001 Executive Boulevard · Bethesda, MD 20892-9663 · 1-866-615-6464 GovDelivery logo

NIH announces winners of high school mental health essay contest

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).

 

09/30/2019 10:00 AM EDT

Speaking Up About Mental Health! essays explored stigma and social barriers in seeking mental health treatment.

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institutes of Health (NIH) · 9000 Rockville Pike · Bethesda MD 20892 · 301-496-4000 / TTY 301-402-9612 GovDelivery logo

First-time pregnancy complications linked to increased risk of hypertension later in life

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).

 

09/30/2019 09:15 AM EDT

Detailed pregnancy history, prevention strategies may hold a key to improving health outcomes.

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institutes of Health (NIH) · 9000 Rockville Pike · Bethesda MD 20892 · 301-496-4000 / TTY 301-402-9612 GovDelivery logo

Friday, September 27, 2019

October is National Protect Your Hearing Month

National Institute on Deafness and Other Communication Disorders

September  27, 2019

It's too loud! Protect your hearing

October is National Protect Your Hearing Month

Woman placing protective earmuffs on preteen boy.

Join the National Institute on Deafness and Other Communication Disorders (NIDCD) as we observe National Protect Your Hearing Month each October to raise awareness about the causes and prevention of noise-induced hearing loss. Nearly 24 percent of U.S. adults ages 20 to 69 have features of their hearing tests in one or both ears that suggest hearing loss from loud noise.

Read more »

Student in lab.

Health Information

Hearing, ear infections, etc.

Balance

Taste and smell

Voice, speech, and language

Dr. Wade Chien and staff

Popular Topics

Do you need a hearing test?

Ear infections

Tinnitus

Stuttering

NIDCD now offers an easy way for you to get trusted, up-to-date content for your website. Learn more about content syndication >>


This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud, on behalf of: National Institute on Deafness and Other Communication Disorders · 31 Center Drive, MSC 2320 ·  Bethesda, MD USA 20892-2320 GovDelivery logo

Selpercatinib for Lung Cancer with RET Alterations - Cancer Currents Blog

National Cancer Institute

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

You are subscribed to Cancer Currents: An NCI Cancer Research Blog from the National Cancer Institute. Recent posts are listed below.

 

 

09/27/2019
The investigational drug selpercatinib may benefit patients with lung cancer whose tumors have alterations in the RET gene, including fusions with other genes, according to results from a small clinical trial.
This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Cancer Institute · BG 9609 MSC 9760 · 9609 Medical Center Drive · Bethesda, MD 20892 GovDelivery logo